Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Current Liabilities: 2019-2022

Historic Total Current Liabilities for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $81.9 million.

  • ADC Therapeutics' Total Current Liabilities fell 10.70% to $78.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $78.2 million, marking a year-over-year decrease of 10.70%. This contributed to the annual value of $81.9 million for FY2022, which is 10.83% up from last year.
  • ADC Therapeutics' Total Current Liabilities amounted to $81.9 million in FY2022, which was up 10.83% from $73.9 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Total Current Liabilities ranged from a high of $81.9 million in FY2022 and a low of $19.9 million during FY2019.
  • Over the past 2 years, ADC Therapeutics' median Total Current Liabilities value was $77.9 million (recorded in 2021), while the average stood at $77.9 million.
  • Data for ADC Therapeutics' Total Current Liabilities shows a peak YoY climbed of 10.83% (in 2022) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Total Current Liabilities (Yearly) stood at $19.9 million in 2019, then reached $73.9 million in 2021, then grew by 10.83% to $81.9 million in 2022.